Truelixir Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
as on 04-01-2025
About Truelixir Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Dhanwanti Devjani and Arvind Devjani serve as directors at the Company.
- CIN/LLPIN
U15100MP2020PTC051897
- Company No.
051897
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jul 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Truelixir Biotech Private Limited offer?
Truelixir Biotech Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Herbal Extracts, Spices Extracts, Floral Extract, Fruit Extracts, Plant Extracts, Ayurvedic Powder and Medicinal Herbs, Herbs,Sticks and Roots.
Who are the key members and board of directors at Truelixir Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Devjani  | Director | 19-Jul-2020 | Current |
| Dhanwanti Devjani | Director | 19-Jul-2020 | Current |
Financial Performance of Truelixir Biotech.
Truelixir Biotech Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Truelixir Biotech?
Unlock access to Truelixir Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Smatt Medichem Private LimitedActive 1 year 4 monthsDhanwanti Devjani and Arvind Devjani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Aug 2021 | ₹2.50 M | Open |
How Many Employees Work at Truelixir Biotech?
Truelixir Biotech has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Truelixir Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Truelixir Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.